Skip to main content

Search articles in R & D

Found 65 articles

  • Danaher Announces Two New Centers of Innovation in

    Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development

    • 18 Jul 2024
    • Editor

    Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, announced the launch of two new Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP)-certified labs intended to accelerate the development of Companion Diagnostics (CDx) and Complementary Diagnostics (CoDx).

  • The Impact of AI on Pharmaceutical R&D and Drug Di

    The Impact of AI on Pharmaceutical R&D and Drug Discovery

    • 17 Jul 2024
    • Lucy Walters

    The future of drug discovery and pharmaceutical research and development is being reshaped by artificial intelligence (AI), heralding a new era of speed, efficiency, and precision. AI’s potential to accelerate drug development, from molecular prediction to optimised design and improved clinical trials, promises to significantly cut costs and time-to-market for new medications.

  • Insider's Guide to Hiring a Scientist

    Insider's Guide to Hiring a Scientist

    • 16 Jul 2024
    • Lucy Walters

    In this recruiter guide, we explore the essential considerations for you to remember when hiring a Scientist. From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will help you focus your candidate search and engage your target audience of talent.

  • Step by Step Guide to Hiring a Scientist

    Step by Step Guide to Hiring a Scientist

    • 16 Jul 2024
    • Lucy Walters

    In this recruiter guide, we explore the essential considerations for you to remember when hiring a Scientist. From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will help you focus your candidate search and engage your target audience of talent.

  • How to Hire a Scientist

    How to Hire a Scientist

    • 16 Jul 2024
    • Lucy Walters

    In this recruiter guide, we explore the essential considerations for you to remember when hiring a Scientist. From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will help you focus your candidate search and engage your target audience of talent.

  • Danaher Launches Beacon Research Collaboration wit

    Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening

    • 12 Jul 2024
    • Editor

    Danaher Corporation (NYSE: DHR), a global science and technology innovator, today launched a research collaboration with Stanford University's Department of Bioengineering intended to shape the future of cancer drug screening through "smart microscopy."

  • Thermo Fisher Scientific to Help Advance Myeloid C

    Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical Research and Treatment Utilizing Next Generation Sequencing Technology

    • 12 Jul 2024
    • Editor

    To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is partnering with the National Cancer Institute (NCI) – part of the National Institutes of Health – on the myeloMATCH (Molecular Analysis for Therapy Choice) precision medicine umbrella trial.

  • What Does a Bioinformatician Do?

    What Does a Bioinformatician Do?

    • 11 Jul 2024
    • Lucy Walters

    Bioinformatics is an interdisciplinary field that integrates computer science, mathematics, statistics, and biology to manage and analyse biological data. This field is crucial to the life sciences industry for its role in understanding complex biological processes, leading to significant advances in drug discovery, genetic research, and personalised medicine.

  • Pfizer to Launch Process to Identify a Successor f

    Pfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Development

    • 11 Jul 2024
    • Editor

    Pfizer Inc. (NYSE: PFE) today announced that the company is launching the process to identify a successor for Dr. Mikael Dolsten, Pfizer’s Chief Scientific Officer and President, Pfizer Research & Development, who will depart the company after a more than 15-year stellar career.

  • AbbVie Announces Appointment of Roopal Thakkar, M.

    AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer

    • 11 Jul 2024
    • Editor

    AbbVie (NYSE:ABBV) today announced that Roopal Thakkar, M.D. who currently serves as senior vice president, chief medical officer, global therapeutics has been appointed to the position of executive vice president, research & development and chief scientific officer. In this position, Dr. Thakkar will lead the company's global R&D organization of more than 14,000 team members across all phases of discovery and development, including therapeutics and aesthetics.

  • Evotec and Pfizer collaborate to advance drug disc

    Evotec and Pfizer collaborate to advance drug discovery in France

    • 10 Jul 2024
    • Editor

    Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced it has entered into a multi-year master research collaboration and option and license agreement with Pfizer. Under the agreement, Evotec and Pfizer will initially focus on early discovery research for metabolic and infectious diseases.

  • Just – Evotec Biologics expands tech partnership f

    Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz

    • 9 Jul 2024
    • Editor

    Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX , ISIN: DE0005664809; NASDAQ: EVO) today announced that its biologics segment, Just – Evotec Biologics, Inc., has expanded its strategic partnership with Sandoz.

  • Agreement to explore Optimer vehicles for targeted

    Agreement to explore Optimer vehicles for targeted delivery of siRNA

    • 3 Jul 2024
    • PharmiWeb Editor

    New collaboration will evaluate Aptamer’s fibrotic liver delivery vehicles with siRNA

  • BioMed X Start Collaboration in Autoimmunity Resea

    BioMed X Start Collaboration in Autoimmunity Research with Servier

    • 27 Jun 2024
    • Editor

    BioMed X, an independent German biomedical research institute, and Servier, an international independent pharmaceutical company, announce the start of a new research team at the BioMed X Institute in Heidelberg to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune diseases.

  • Lilly collaborates with OpenAI to discover novel m

    Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria

    • 26 Jun 2024
    • Editor

    Eli Lilly and Company (NYSE: LLY) announced a collaboration with OpenAI that will allow Lilly to leverage OpenAI's generative AI to invent novel antimicrobials to treat drug-resistant pathogens. Antimicrobial resistance (AMR) is one of the top public health and development threats across the global health landscape.

  • BioMed X Launches New US Institute in New Haven, C

    BioMed X Launches New US Institute in New Haven, CT

    • 14 Jun 2024
    • Editor

    BioMed X, an independent research institute founded in Heidelberg, Germany, has expanded its operations with the opening of a new institute in the United States. Located in New Haven, CT, in the vicinity of Yale University, the new facilities are part of the Elm City Bioscience Center, a state-of-the-art lab and research building owned by The Hurley Group.

  • IQVIA Institute: Innovative Therapies and Strong P

    IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses

    • 11 Jun 2024
    • Editor

    As cancer incidence continues to rise, it’s being met by wider use of innovative therapies and a robust pipeline of new drugs, according to a new report from the IQVIA Institute for Human Data Science titled, “Global Oncology Trends 2024: Outlook to 2028.”

  • Labcorp Announces New Strategic Service Offerings

    Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio

    • 4 Jun 2024
    • Editor

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced new strategic service offerings within its precision oncology portfolio.

  • Evotec and QIAGEN enter software collaboration for

    Evotec and QIAGEN enter software collaboration for enhanced multi-omics data insights

    • 3 Jun 2024
    • Editor

    Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration to leverage QIAGEN’s OmicSoft Land Databases through Evotec’s PanOmics data access and analysis platform PanHunter.

  • Evotec, Inserm, Lille University Hospital and Inse

    Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases

    • 30 May 2024
    • Editor

    Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the Company entered a partnership with Inserm, the French National Institute of Health and Medical Research, Lille University Hospital and Inserm Transfert (the private subsidiary of Inserm) to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases.